Synthesis and antineoplastic activity of some cyano-, carboxy-, carbomethoxy-, and carbamoylborane adducts of heterocyclic amines
- PMID: 1815071
- DOI: 10.1002/jps.2600801209
Synthesis and antineoplastic activity of some cyano-, carboxy-, carbomethoxy-, and carbamoylborane adducts of heterocyclic amines
Abstract
Boron analogues of piperidine, piperazine, morpholine, and imidazole proved to be cytotoxic against the growth of murine and human tissue culture cells. Significant activity was demonstrated for single-cell suspensions of L1210 lymphoid leukemia, Tmolt3 lymphoblastic leukemia, and HeLa-S3 cervical carcinoma. Trimethylamine-imidazole carbonyldihydroborane 17 demonstrated activity against solid tumor growth of human colorectal adenocarcinoma, KB nasopharynx, and osteosarcoma. In addition, 4-methylpiperidine-carbomethoxyborane 12, 2-methylimidazole-3-cyanoborane 16, and 1-methylimidazole-3-(N-ethylcarbamoyl)borane 19 were active against the KB nasopharynx growth. Piperidine-cyanoborane 2, piperidine-carboxyborane 4, and 1-methylimidazole-3-(N-ethylcarbamoyl)borane 19 were effective in reducing the growth of osteosarcoma cells. The imidazole derivatives 13-19, as well as 4-methylpiperidine-carboxyborane 11 and carbomethoxyborane 12, demonstrated good activity against lung bronchogenic and glioma growth. In the in vivo studies, N-methylmorpholine-carboxyborane 7,4-phenylpiperidine-carboxyborane 9, 4-phenylpiperidine-carbomethoxyborane 10, 4-methylpiperidine-carboxyborane 11, imidazole cyanoborane 14, and 1-methylimidazole-3-carbomethoxyborane 18 demonstrated the best activity against Lewis Lung growth and P388 lymphocytic leukemia growth in mice. Mode of action studies in L1210 leukemia cells demonstrated that piperidine-carboxyborane 4 and N-methylmorpholine-carboxyborane 7 inhibited DNA synthesis, purine synthesis at PRPP amido transferase and IMP dehydrogenase sites, and thymidine kinase and thymidine diphosphate kinase activities, while lowering d(NTP) pool levels. Also, DNA strand scission was evident after incubation with these drugs.
Similar articles
-
Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.Environ Health Perspect. 1994 Nov;102 Suppl 7(Suppl 7):21-30. doi: 10.1289/ehp.94102s721. Environ Health Perspect. 1994. PMID: 7889876 Free PMC article. Review.
-
Relationship of hypolipidemic and antineoplastic activities of tricyclohexyl- and triphenylphosphine boranes, carboxyboranes, cyanoboranes, and related derivatives.Arch Pharm (Weinheim). 1992 May;325(5):267-72. doi: 10.1002/ardp.19923250504. Arch Pharm (Weinheim). 1992. PMID: 1524468
-
Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells.Anticancer Res. 1992 Jul-Aug;12(4):1091-7. Anticancer Res. 1992. PMID: 1503401
-
Synthesis and pharmacological activities of amine-boranes.Curr Med Chem. 2005;12(17):1995-2010. doi: 10.2174/0929867054546573. Curr Med Chem. 2005. PMID: 16101500 Review.
-
Synthesis and cytotoxicity of amine-borane adducts of cyclohexylamines and toluidines.Pharmazie. 1995 Dec;50(12):779-83. Pharmazie. 1995. PMID: 8584554
Cited by
-
Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.Environ Health Perspect. 1994 Nov;102 Suppl 7(Suppl 7):21-30. doi: 10.1289/ehp.94102s721. Environ Health Perspect. 1994. PMID: 7889876 Free PMC article. Review.
-
Lipid-lowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole- 4-carboxylates in rodents.Molecules. 2004 Feb 28;9(3):134-57. doi: 10.3390/90300134. Molecules. 2004. PMID: 18007418 Free PMC article.
-
The effects of boron containing peptides on L1210 lymphoid leukemia metabolism.Amino Acids. 1993 Oct;4(3):287-302. doi: 10.1007/BF00805829. Amino Acids. 1993. PMID: 24190609
-
A Facile Synthesis of Carbamoylsilanes, -boranes and -phosphane Oxides - Isolation of the First Uncomplexed Carbamoylborane.Eur J Inorg Chem. 2006 Dec 1;2006(24):5076-5080. doi: 10.1002/ejic.200600799. Eur J Inorg Chem. 2006. PMID: 19763185 Free PMC article.
-
Synthesis of biologically active boron-containing compounds.Medchemcomm. 2017 Nov 28;9(2):201-211. doi: 10.1039/c7md00552k. eCollection 2018 Feb 1. Medchemcomm. 2017. PMID: 30108914 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources